Biblio

2013
Caserta S, Barra M, Manganelli G, Tomaiuolo G, Filosa S, Cassinese A, Guido S. Cardiomyocyte differentiation of embryonic stem 
cells on the surface of organic semiconductors. Int J Artif Organs. 2013.
Pradhapan P, Kuusela J, Viik J, Aalto-Setälä K, Hyttinen J. Cardiomyocyte MEA Data Analysis (CardioMDA) - A Novel Field Potential Data Analysis Software for Pluripotent Stem Cell Derived Cardiomyocytes. PLoS One. 2013;8(9):e73637.
Yu B, Gong M, Wang Y, Millard RW, Pasha Z, Yang Y, Ashraf M, Xu M. Cardiomyocyte Protection by GATA-4 Gene Engineered Mesenchymal Stem Cells Is Partially Mediated by Translocation of miR-221 in Microvesicles. PLoS One. 2013;8(8):e73304.
Akagi K, Kawai T, Watanabe N, Yokoyama M, Arai K, Harayama S, Oana S, Onodera M. A Case of Macrophage Activation Syndrome Developing in a Patient With Chronic Granulomatous Disease-associated Colitis. J Pediatr Hematol Oncol. 2013.
Omes C, Fassina L, Van Vlierberghe S, Magenes G, Dubruel P, Vaghi P, Reguzzoni M, Riva F. A case of successful interaction between cells derived from human ovarian follicular liquid and gelatin cryogel for biotech and medical applications. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:6240-6243.
Agarwal M, Nitta RT, Li G. Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells. J Mol Genet Med. 2013;8(1).
Potapova IA, Cohen IS, Doronin SV. Caspases and p38 MAPK Regulate Endothelial Cell Adhesiveness for Mesenchymal Stem Cells. PLoS One. 2013;8(9):e73929.
Chang Y-C, Jang AC-C, Lin C-H, Montell DJ. Castor is required for Hedgehog-dependent cell-fate specification and follicle stem cell maintenance in Drosophila oogenesis. Proc Natl Acad Sci U S A. 2013.
Yen J, Zhang Y, Gabrielson NP, Yin L, Guan L, Chaudhury I, Lu H, Wang F, Cheng J. Cationic, helical polypeptide-based gene delivery for IMR-90 fibroblasts and human embryonic stem cells. Biomater Sci. 2013;1(7):719-727.
Mandoli A, Singh AA, Jansen PWTC, Wierenga ATJ, Riahi H, Franci G, Prange K, Saeed S, Vellenga E, Vermeulen M, et al. CBFB-MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv(16) acute myeloid leukemia. Leukemia. 2013.
Joly W, Chartier A, Rojas-Rios P, Busseau I, Simonelig M. The CCR4 Deadenylase Acts with Nanos and Pumilio in the Fine-Tuning of Mei-P26 Expression to Promote Germline Stem Cell Self-Renewal. Stem Cell Reports. 2013;1(5):411-424.
Solana J, Gamberi C, Mihaylova Y, Grosswendt S, Chen C, Lasko P, Rajewsky N, A Aboobaker A. The CCR4-NOT Complex Mediates Deadenylation and Degradation of Stem Cell mRNAs and Promotes Planarian Stem Cell Differentiation. PLoS Genet. 2013;9(12):e1004003.
Kim M-G, Kim SHee, Noh H, Ko YSook, Lee HYoung, Jo S-K, Cho WYong, Kim HKyu. CD11c(+) Cells Partially Mediate the Renoprotective Effect Induced by Bone Marrow-Derived Mesenchymal Stem Cells. PLoS One. 2013;8(8):e72544.
Ren F, Sheng W-Q, Du X. CD133: A cancer stem cells marker, is used in colorectal cancers. World J Gastroenterol. 2013;19(17):2603-2611.
Nadal R, F Ortega G, Salido M, Lorente JA, Rodríguez-Rivera M, Delgado-Rodríguez M, Macià M, Fernández A, Corominas JM, J García-Puche L, et al. CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy. Int J Cancer. 2013.
Nam-Cha SH, Serrano-Vargas R, Escario E, Azaña JM, Calero-Oliver R, Martín AG, Poblet E. CD133 Expression in Normal Skin and in Epithelial Cutaneous Tumors. Biomed Res Int. 2013;2013:385604.
Irollo E, Pirozzi G. CD133: to be or not to be, is this the real question?. Am J Transl Res. 2013;5(6):563-581.
Varin A, Pontikoglou C, Labat E, Deschaseaux F, Sensébé L. CD200R/CD200 Inhibits Osteoclastogenesis: New Mechanism of Osteoclast Control by Mesenchymal Stem Cells in Human. PLoS One. 2013;8(8):e72831.
Imai T, Tamai K, Oizumi S, Oyama K, Yamaguchi K, Sato I, Satoh K, Matsuura K, Saijo S, Sugamura K, et al. CD271 Defines a Stem Cell-Like Population in Hypopharyngeal Cancer. PLoS One. 2013;8(4):e62002.
Yang J, Ikezoe T, Nishioka C, Nobumoto A, Udaka K, Yokoyama A. CD34(+) /CD38(-) acute myelogenous leukemia cells aberrantly express aurora kinase A. Int J Cancer. 2013.
Lee JHee, Lee SHun, Yoo SYoung, Asahara T, Kwon SMo. CD34 Hybrid Cells Promote Endothelial Colony-Forming Cell Bioactivity and Therapeutic Potential for Ischemic Diseases. Arterioscler Thromb Vasc Biol. 2013.
Vrtovec B, Poglajen G, Sever M, Lezaic L, Socan A, Haddad F, Wu JC. CD34(+) Stem Cell Therapy in Non-Ischemic Dilated Cardiomyopathy Patients. Clin Pharmacol Ther. 2013.
Roudi R, Madjd Z, Ebrahimi M, Samani FSahraneshi, Samadikuchaksaraei A. CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549. Cell Mol Biol Lett. 2013.
Zeilstra J, Joosten SPJ, Vermeulen L, Koster J, Medema JPaul, Versteeg R, Spaargaren M, Pals ST. CD44 Expression in Intestinal Epithelium and Colorectal Cancer Is Independent of p53 Status. PLoS One. 2013;8(8):e72849.
Sun M, Zhou W, Zhang Y-Y, Wang D-L, Wu X-L. CD44(+) gastric cancer cells with stemness properties are chemoradioresistant and highly invasive. Oncol Lett. 2013;5(6):1793-1798.

Pages